Group 1 - The company held its 44th meeting of the 5th Board of Directors on July 31, 2025, with all 9 directors present, and the meeting complied with relevant laws and regulations [1] - The Board approved a proposal to register and issue medium-term notes to optimize the company's debt structure, in accordance with Chinese laws and regulations [1][2] - The proposal to authorize the Board to handle all matters related to the registration and issuance of medium-term notes was also approved, requiring submission to the 2025 first extraordinary shareholders' meeting for further approval [2]

Group 1 - The core point of the announcement is that the company plans to register and issue medium-term notes to optimize and adjust its debt structure [1][2] - The meeting of the supervisory board was held on July 31, 2025, with all three supervisors present, and the decision to issue medium-term notes was unanimously approved [1][2] - The proposal for the issuance of medium-term notes will be submitted for review at the company's first extraordinary general meeting of shareholders in 2025 [2] Group 2 - The issuance of medium-term notes is in compliance with relevant laws and regulations, including the Company Law and the Management Measures for Non-Financial Enterprise Debt Financing Instruments in the Interbank Bond Market [1] - The company assures that the issuance does not harm the interests of minority shareholders [1]

证券代码：300729 证券简称：乐歌股份 公告编号：2025-058 模将以公司在中国银行间市场交易商协会取得的注册通知书载明的额度及公司 实际发行需要为准； 的最终结果确定； 公司的资金需求及市场情况确定； 式根据市场情况和公司资金需求情况确定； 购买者除外）； 债券代码：123072 债券简称：乐歌转债 乐歌人体工学科技股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 乐歌人体工学科技股份有限公司（以下简称"公司"）于 2025 年 7 月 31 日召开的第五届董事会第四十四次会议审议通过了《关于申请注册发行中期票据 的议案》。为进一步优化和调整公司负债结构，根据《中华人民共和国公司法》 《银行间债券市场非金融企业债务融资工具管理办法》等法律、法规的规定，结 合公司发展需要，公司拟向中国银行间市场交易商协会申请注册发行中期票据。 现将有关事项公告如下： 一、本次注册发行中期票据的基本方案 册登记手续、发行及交易流通等有关事项手续； 规定必须由公司股东大会重新表决的事项外，可依据监管部门的意见对本次发行 的具体方案等相关事项进行相应调整； 票据 ...

证券日报网讯 7月31日晚间，乐歌股份发布公告称，公司第五届监事会第三十三次会议审议通过了《关 于拟注册和发行中期票据的议案》。 （文章来源：证券日报） ...

证券日报网讯 7月31日晚间，乐歌股份发布公告称，公司第五届董事会第四十四次会议审议通过了《关 于拟注册和发行中期票据的议案》等。 （文章来源：证券日报） ...

Group 1 - Jiejia Weichuang expects a net profit of 1.7 billion to 1.96 billion yuan for the first half of 2025, representing a year-on-year increase of 38.65% to 59.85% [1] - Micron Biotech's CS231295 clinical trial application has been approved by the FDA for treating advanced solid tumors [1] - Sinopec anticipates a net profit of 20.1 billion to 21.6 billion yuan for the first half of 2025, a decrease of 39.5% to 43.7% year-on-year [2] Group 2 - High Energy Environment has obtained a loan commitment letter from a financial institution for share repurchase [2] - Electric Power Investment Energy received a warning letter from the Inner Mongolia Securities Regulatory Bureau for inadequate disclosure in its semi-annual report [3] - Zhejiang University Net New won a bid for an intelligent engineering project worth 94.2712 million yuan [5] Group 3 - Daodaoquan reported a net profit of 181 million yuan for the first half of 2025, a year-on-year increase of 563.15% [8] - New Light Optoelectronics expects a net loss of 19 million to 23 million yuan for the first half of 2025 [9] - Aihua Pharmaceutical's two probiotic powder registration applications have been accepted [10] Group 4 - Xinhui Electric's subsidiary signed a product sales framework contract for commercial and household robots [11] - Baida Precision Engineering's subsidiary obtained 134,500 square meters of industrial land use rights [12] - Haiyang Technology's chief engineer resigned for personal reasons [13] Group 5 - Tianhe Magnetic Materials received a project filing notice for a 12,000-ton magnetic material deep processing project [22] - Wanlima is the pre-selected unit for a procurement project worth 43.835 million yuan from China Southern Airlines [24] - Yipin Hong's subsidiaries obtained two drug registration certificates [25] Group 6 - Zhejiang Jiaoke's subsidiary signed new construction projects worth 4.783 billion yuan in the second quarter [27] - Shenglan Co. received approval for issuing convertible bonds [29] - Jimi Technology expects a net profit of 88.6622 million yuan for the first half of 2025, a year-on-year increase of 2062.33% [31] Group 7 - Dingtong Technology reported a net profit of 115 million yuan for the first half of 2025, a year-on-year increase of 134.06% [32] - Huaheng Biological is planning to list on the Hong Kong Stock Exchange [34] - Yuntian Lihui submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [36] Group 8 - Nanchip Technology expects a net profit of 108.8 million to 133.1 million yuan for the first half of 2025, a decrease of 35.09% to 47.03% year-on-year [43] - Anglikang's Mesobam injection has received a drug registration certificate [44] - Jida Zhengyuan's shareholder plans to reduce their stake by up to 0.998% [45]

Group 1 - The core point of the article is that Lege Co., Ltd. announced a board meeting to discuss the proposal for the registration and issuance of medium-term notes [2] - The meeting took place on July 31, 2025, in Ningbo, combining in-person and communication methods [2] - For the year 2024, the revenue composition of Lege Co., Ltd. is 57.26% from the furniture manufacturing industry and 42.74% from warehousing and logistics services [2]

| 证券代码：300729 | 证券简称：乐歌股份 公告编号：2025-057 | | --- | --- | | 债券代码：123072 | 债券简称：乐歌转债 | 乐歌人体工学科技股份有限公司 第五届监事会第三十三次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 （一）审议通过《关于拟注册和发行中期票据的议案》 为进一步优化和调整公司负债结构，根据《中华人民共和国公司法》《银 行间债券市场非金融企业债务融资工具管理办法》等法律、法规的规定，结合 公司发展需要，公司拟向中国银行间市场交易商协会申请注册发行中期票据。 公司本次申请注册发行中期票据，是为进一步优化和调整公司负债结构，符合 《公司法》《银行间债券市场非金融企业债务融资工具管理办法》等法律、法 规以及《公司章程》的规定，不存在损害中小股东利益的情况。 具体内容详见公司披露于巨潮资讯网（http://www.cninfo.com.cn）的《关 于拟注册和发行中期票据的公告》（公告编号：2025-058)。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 本议案需提交公司 2025 ...

| 证券代码：300729 | 证券简称：乐歌股份 公告编号：2025-056 | | --- | --- | | 债券代码：123072 | 债券简称：乐歌转债 | 乐歌人体工学科技股份有限公司 第五届董事会第四十四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 表决结果：同意 9 票，反对 0 票，弃权 0 票。 一、董事会会议召开情况 乐歌人体工学科技股份有限公司（以下简称"公司"）第五届董事会第四十 四次会议于 2025 年 7 月 31 日（星期四）在宁波市鄞州区首南街道学士路 436 号 乐歌大厦会议室以现场结合通讯的方式召开。本次会议经全体董事一致同意豁免 会议通知时间要求，会议通知以口头、通讯方式向全体董事送达。本次会议应出 席董事 9 人，实际出席董事 9 人。 会议由董事长、总经理项乐宏主持，公司监事及部分高管列席。会议召开符 合有关法律、法规、规章和《公司章程》的规定。 二、董事会会议审议情况 经各位董事认真审议，会议形成了以下决议： （一）审议通过《关于拟注册和发行中期票据的议案》 为进一步优化和调整公司负债结构，根据《 ...

| 证券代码：300729 | 证券简称：乐歌股份 公告编号：2025-059 | | --- | --- | | 债券代码：123072 | 债券简称：乐歌转债 | 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 乐歌人体工学科技股份有限公司（以下简称"公司"）第五届董事会第四十 三次会议决定于 2025 年 8 月 12 日（星期二）下午 14:00 召开 2025 年第一次临 时股东会，具体内容详见公司于 2025 年 7 月 26 日在中国证监会指定创业板信息 披露网站发布的《关于召开 2025 年第一次临时股东会的通知》。 2025 年 7 月 31 日，公司召开第五届董事会第四十四次会议，审议通过了《关 于拟注册和发行中期票据的议案》《关于提请股东会授权董事会全权办理本次注 册发行中期票据相关事宜的议案》2 项议案。上述议案尚需提交公司股东会审议。 为提高公司决策效率，公司董事会于 2025 年 7 月 31 日收到实际控制人项乐宏先 生（直接持有公司 15,048,295 股股份，占总股份 4.41%）提交的《关于提请增 加 2025 年第一次临 ...